Effectiveness of Bariatric Surgery and Incretin-based Therapies on Cardiovascular Outcomes in Patients with Obesity: A Systematic Review and Network Meta-Analysis

Abstract Background Bariatric surgery and pharmacological weight-loss therapies improve cardiometabolic risk factors. However, direct head-to-head comparisons assessing their impact on cardiovascular outcomes remain limited. We performed an exploratory meta-analysis to compare bariatric surgery and pharmacological weight-loss therapies on major clinical outcomes in adults with obesity. Methods A systematic literature search using PubMed and Scopus databases was conducted. Randomized and observational studies comparing bariatric surgery or incretin receptor agonists with controls were included in the analysis. The primary outcomes were all-cause mortality and MACE. A frequentist random-effects network meta-analysis was conducted across three nodes. Results A total of 40 studies, comprising more than 1.9 million patients, were included in the meta-analysis. Compared with control, bariatric surgery was associated with a significant reduction in all evaluated outcomes, including all-cause mortality (HR:0.57, 95%CI:0.51–0.65), MACE (HR:0.54, 95%CI:0.45–0.64), cardiovascular mortality, heart failure hospitalization, myocardial infarction, and stroke. Incretin receptor agonists were also associated with lower all-cause mortality (HR:0.62, 95%CI:0.52–0.74), lower MACE (HR:0.75, 95%CI:0.61-0.92) and reduced heart failure hospitalization. All-cause mortality-representing the most direct and clinically relevant endpoint-did not differ significantly between the two strategies in the exploratory network meta-analysis. Importantly, the network estimates should be cautiously interpreted, given the predominance of observational evidence, substantial heterogeneity, and very low confidence across all comparisons. Conclusion Bariatric surgery and incretin receptor agonists are associated with substantial reductions in major cardiovascular outcomes in adults with obesity. In head-to-head comparisons, no significant differences were observed in all-cause mortality and stroke. Both strategies provide clinically meaningful benefits.

Authors

Institutions

Publication Details

Journal
European Journal of Preventive Cardiology
Published
2026-11-17
DOI
https://doi.org/10.1093/eurjpc/zwag588
Primary Topic
Bariatric Surgery and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effectiveness of Bariatric Surgery and Incretin-based Therapies on Cardiovascular Outcomes in Patients with Obesity: A Systematic Review and Network Meta-Analysis

Ουρανία Κατσαρού, Evangelos Menenakos, Vaia Lambadiari, Savvas Sarantos et al.
European Journal of Preventive Cardiology
Bariatric Surgery and Outcomes
article

Effectiveness of Bariatric Surgery and Incretin-based Therapies on Cardiovascular Outcomes in Patients with Obesity: A Systematic Review and Network Meta-Analysis

Ουρανία Κατσαρού, Evangelos Menenakos, Vaia Lambadiari, Savvas Sarantos, Loukia Pliouta, Gerasimos Siasos, Anastasios Roumeliotis, Panagiotis Theofilis, Antonios Lysandrou, Panagiota K. Stampouloglou, Evangelos K. Oikonomou, Niki Tripyla, Emmanouil Korakas, Nikolaos Vythoulkas-Biotis, ELIAS J. GIALAFOS, Alexios Giannakodimos
article en

Abstract

Abstract Background Bariatric surgery and pharmacological weight-loss therapies improve cardiometabolic risk factors. However, direct head-to-head comparisons assessing their impact on cardiovascular outcomes remain limited. We performed an exploratory meta-analysis to compare bariatric surgery and pharmacological weight-loss therapies on major clinical outcomes in adults with obesity. Methods A systematic literature search using PubMed and Scopus databases was conducted. Randomized and observational studies comparing bariatric surgery or incretin receptor agonists with controls were included in the analysis. The primary outcomes were all-cause mortality and MACE. A frequentist random-effects network meta-analysis was conducted across three nodes. Results A total of 40 studies, comprising more than 1.9 million patients, were included in the meta-analysis. Compared with control, bariatric surgery was associated with a significant reduction in all evaluated outcomes, including all-cause mortality (HR:0.57, 95%CI:0.51–0.65), MACE (HR:0.54, 95%CI:0.45–0.64), cardiovascular mortality, heart failure hospitalization, myocardial infarction, and stroke. Incretin receptor agonists were also associated with lower all-cause mortality (HR:0.62, 95%CI:0.52–0.74), lower MACE (HR:0.75, 95%CI:0.61-0.92) and reduced heart failure hospitalization. All-cause mortality-representing the most direct and clinically relevant endpoint-did not differ significantly between the two strategies in the exploratory network meta-analysis. Importantly, the network estimates should be cautiously interpreted, given the predominance of observational evidence, substantial heterogeneity, and very low confidence across all comparisons. Conclusion Bariatric surgery and incretin receptor agonists are associated with substantial reductions in major cardiovascular outcomes in adults with obesity. In head-to-head comparisons, no significant differences were observed in all-cause mortality and stroke. Both strategies provide clinically meaningful benefits.

European Journal of Preventive Cardiology
National and Kapodistrian University of Athens (GR), Laiko General Hospital of Athens (GR), University General Hospital Attikon (GR), Hippocration General Hospital (GR), Sotiria General Hospital (GR)
Bariatric Surgery and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon